The role of comprehensive renal clinic in chronic kidney disease stabilization and management: The Northwestern experience

Seminars in Nephrology

Volumn 22, Issue 6, 2002, Pages 526-532

  Ghossein, Cybele ^a   Serrano, Andres ^a   Rammohan, Meena ^a   Batlle, Daniel ^a  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN;

ANEMIA; CHRONIC KIDNEY DISEASE; DIALYSIS; GLOMERULUS FILTRATION RATE; HEALTH SERVICE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; PATIENT CARE; PATIENT EDUCATION; PRIORITY JOURNAL; REVIEW; VASCULAR ACCESS; CHRONIC KIDNEY FAILURE; HEALTH CARE; HEALTH CARE QUALITY; NUTRITIONAL SUPPORT; OUTPATIENT DEPARTMENT; PATIENT REFERRAL; PRACTICE GUIDELINE; RENAL REPLACEMENT THERAPY; STANDARD; UNITED STATES;

AMBULATORY CARE FACILITIES; ANEMIA; CHICAGO; COMPREHENSIVE HEALTH CARE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; NUTRITIONAL SUPPORT; PRACTICE GUIDELINES; QUALITY ASSURANCE, HEALTH CARE; REFERRAL AND CONSULTATION; RENAL DIALYSIS;

EID: 0036849925     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1053/snep.2002.35970     Document Type: Article

References (31)

1. US Renal Data System: USRDS 2001 Annual Data Report: Atlas of End Stage Renal Disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, 2001
2. Arora P, Obrador GT, Ruthazer R, et al: Prevalence predictors, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol 10:1281-1286, 1999
3. US Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health (2nd Ed.). Washington, DC, US Government Printing Office, 2000
4. NIH consensus statement: Morbidity and mortality of dialysis patients. Ann Intern Med 121:62, 1994
5. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 39:2S, 2002
6. Arora P, Obrador GT, Ruthazer R, et al: Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol 10:1281-1286, 1999
7. Ifudu O, Dawood M, Homel P, et al: Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. Am J Kidney Dis 28:841-845, 1996
8. Winkelmayer W, Glynn R, Levin R, et al: Determinants of delayed nephrologist referral in patients with chronic kidney disease. Am J Kidney Dis 38:1178, 2001
9. Campbell JD, Ewigman B, Hosokawa M, et al: The timing of referral of patients with end stage renal disease. Nephrol Dial Transplant 18:660, 1989
10. Portoles J, Torralbo A, Martin P, et al: Cardiovascular effects of recombinant human erythropoietin in pre-dialysis patients. Am J Kidney Dis 29:541-548, 1997
11. Hayashi T, Suzuki A, Shoji T, et al: Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in pre dialysis patients with chronic renal failure. Am J Kidney Dis 35:250-256, 2000
12. Revicki DA, Brown RE, Feeny DH, et al: Health-related quality of life associated with recombinant human erythropoietin therapy for pre dialysis chronic renal disease patients. Am J Kidney Dis 25:548-554, 1995
13. Wolcott DL, Marsh JT, La Rue A, et al: Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients. Am J Kidney Dis 14:478-485, 1989
14. Malluche HH, Ritz E, Lange HP, et al: Bone histology in incipient and advanced renal failure. Kidney Int 9:355-362, 1976
15. Hamdy N, Kanis J, Beneton M, et al: Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure BMJ 310:358-363, 1995
16. Port F: Morbidity and mortality in dialysis patients. Kidney Int 46:1728-1737, 1994
17. Mange KC, Joffe MM, Feldman HH: Effect of the use or non use of long term dialysis on the subsequent survival of renal transplant from living donors. N Engl J Med 344:726-731, 2001
18. Cecka JM: Kidney transplantation from living and related donors. Ann Rev Med 61:393-406, 2000
19. Diaz-Buxo JA: Early referral and selection of peritoneal dialysis as a treatment modality. Nephrol Dial Transplant 15: 147-149, 2000
20. Diaz-Buxo JA: The importance of pre-ESRD education and early nephrological care in the peritoneal dialysis selection and outcome. Peritoneal Dial Int 18:363-365, 1998
21. Khlar S. Levey AS, Beck GJ, et al: The effect of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330:877-884, 1994
22. Levey AS, Green T, Beck GJ, et al for the MDRD Study Group: Dietary protein restriction and the progression of chronic renal disease: What have all the results of the MDRD study shown? J Am Soc Nephrol 10:2426-2439, 1999
23. Kausz AT, Khan SS, Abichandani R, et al: Management of patients with chronic renal insufficiency in the northeastern United States. J Am Soc Nephrol 12: 1501-1507, 2001
24. Remuzzi G, Ruggenenti P, Perico N: Chronic renal diseases: Renoprotective benefits of renin-angiotensin system inhibition. Ann Intern Med 136:604-615, 2002
25. Pinto-Sietsma S-J, Mulder J, Janssen W, et al: Smoking is related to albuminuria and abnormal renal function in non-diabetic persons. Ann Intern Med 133:585-591, 2000
26. Chuahirum T. Wesson D: Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE-inhibition. Am J Kidney Dis 39:376-382, 2002
27. Jungers P, Choukroun G, Oulim Z, et al: Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients. Nephrol Dial Transplant 16:307-312, 2001
28. Serrano A, Ghossein C, Batlle D: Stabilization of GFR in patients with CKD stratified as per K/DOQI guidelines: Impact of care in CKD. ASN 35th Annual Meeting, Philadelphia, PA, 2002. J Am Soc Nephrol 13:621A, 2002 (abstr)
29. K/DOQ1 clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcome Initiative. Am J Kidney Dis 39:S1-S246, 2002 (suppl 2)
30. McClellan W, Oven W: Preliminary results of the prevalence of anemia in patients (pts) with early renal insufficiency (RAERI) study. J Am Soc Nephrol 12:227, 2001 (abstr)
31. Provenzano R, Lorber D, McClellan W: Prevalence of anemia in diabetic patients with chronic kidney disease and treatment with epoietin alfa once weekly. Am J Kidney Dis 39:A26, 2002 (abstr)